Solicitation Number:  36C10X27Q0014  Notice Type:  Combined Synopsis/Solicitation  This is a combined synopsis/solicitation for brand name, or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued. Solicitation number 36C10X27Q0014 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Quote (RFQ). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2026-01, dated 13 March 2026. Requirement Description: VA has a requirement to purchase Autotransfusion Units to deliver patient care to its VA Medical Centers around the country. An Autotransfusion Units also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care. A single award Requirements contract will be awarded as a Brand Name or Equal in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Quotes shall contain the terms for cost/price and technical capabilities of the brand name or equal equipment. The Government reserves the right to award without discussions.  The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 Surgical and Medical Instrument Manufacturing, Product Service Code: 6515 Medical and Surgical Instruments, Equipment, and Supplies. The associated size standard is 800 employees. This procurement action is Unrestricted Full and Open. This acquisition is for a single award Requirements contract in accordance with FAR Part 16.5 for Haemonetics Call Saver® Elite® + brand name or equal to Autotransfusion Units as identified in ATTACHMENT A PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS. All interested companies shall provide a QUOTE for all Contract Line-Item Numbers (CLINs) listed in ATTACHMENT A PRICE COST SCHEDULE - NX EQ AUTOTRANSFUSION UNITS. The ordering period is for one 12-month base year with four 12-month option years. Delivery is a FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.  The FAR provision at 52.212-1, Instructions to Offerors Commercial Products and Commercial Services, applies to this acquisition including attached addenda to the provision. The FAR provision at 52.212-2, Evaluation -- Commercial Products and Commercial Services Items, and the specific evaluation criteria as attached addenda also applies to this acquisition. Clause 52.212-4, Terms and Conditions -- Commercial Products and Commercial Services, applies to this acquisition and a statement regarding any addenda to the clause. Addendum is attached. All interested quoters must be registered in the System for Award Management (SAM) prior to submitting a quote. You may access SAM at https://sam.gov/SAM/. Questions regarding this combined synopsis/solicitation are due via email by 10:00 AM Eastern Standard Time (EST) on November 16, 2026, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, Sara Vickroy at Sara.Vickroy@va.gov No calls will be accepted. Quotes are due via email by 10:00 AM EST on November 23, 2026, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, Sara Vickroy at Sara.Vickroy@va.gov SCOPE OF WORK   The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified Autotransfusion Units product line as a candidate for a VA-wide (otherwise referred to as national ) single Requirements contract award.  Autotransfusion Units, also known as an autologous blood recovery system, is a system that provides hospitals with an easy-to-use, reliable way to recover a patient s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular and OBGYN surgeries. Once recovered, the blood is washed and delivered to a product bag. The complete system is designed to be intuitive and flexible for optimal performance, supporting exceptional patient care. The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Autotransfusion Units to be used by VHA clinicians throughout the United States and its territories. The period of performance is for one 12-month base period with four 12-month option periods. 2. REQUIREMENT This requirement will be, Brand Name or Equal which requires the quoter indicate that each product being offered as an equal product to Haemonetics Call Saver® Elite® + or equal Autotransfusion Units. For each equal product, the quoter must include a description reflecting the salient characteristics (SCs) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The quoter must also clearly identify the item by brand name (if any) and make/model number. Finally, the offeror must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer (CO) and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements. The following line-items comprise the Autotransfusion Units product line: Contract Line-Item Number Brand Part Number Description 0001 Haemonetics 00205-00 RESERVOIR, HARD-SHELL, 150u 0002 Haemonetics 00208-00 BASIC A & A ASSEMBLY, LN 208 0003 Haemonetics 00220-00 RESERVOIR, HARD-SHELL, 20U 0004 Haemonetics 00245-00 RBC BAG W/TWIST-LOCK CONNECTOR 0005 Haemonetics CSE-B-1000 BAG ASSY, WASTE, 10L 0006 Haemonetics CSE-FP-125V CE ELITE FASTPACK,125mL,150u 0007 Haemonetics CSE-FP-225V CS ELITE FASTPACK,225ML,150U 0008 Haemonetics CSE-P-125 CS ELITE PROCESSING KIT, 125ML 0009 Haemonetics CSE-P-225 CS ELITE PROCESSING KIT, 225ML 0010 Haemonetics CSE-P-70 CS ELITE PROCESSING KIT, 70ML 0011 Haemonetics CSE-SQ-1000 SEQUESTRATION KIT, CSE-SQ-1000 0012 Haemonetics HAR-A-1000 VACUUM LINE, FILTERED 0013 Haemonetics HAR-A-0013 ASPIRATION & ANTICOAG LINE 0014 Haemonetics CSE-EX-US CELL SAVER ELITE PLUS, US 0015 Haemonetics RECERTIFICATION ANNUAL ONLINE RECERTIFICATION 0016 Haemonetics Cell saver Service 1 Year Platinum Service Agreement 0017 Haemonetics Training Tuition Training The Department of Veterans Affairs (VA) is seeking vendors who can provide Haemonetics Call Saver® Elite® + brand name or equal to Autotransfusion Units as listed above which meet all the following salient characteristics. Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Products quoted in the technical volume must be captured on the Vendor s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may quote any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor s pricing volume with a quantity of zero. SC # Salient Characteristics Method of Evaluation Applicable CLINs Page # Where SC is Found in Technical Literature SC1 Collects, separates, washes, and concentrates red blood cells to produce packed RBCs for reinfusion. Literature Review 0014 SC2 Provides multiple automated processing modes (standard, low volume/pediatric, rapid/emergency) with defined throughput/output rates that support continuous or rapid access to washed RBCs during surgery. Literature Review 0014 SC3 Produces high hematocrit washed RBCs with high RBC recovery achieving a strong removal of non RBC components (plasma proteins, free hemoglobin, anticoagulant, potassium, fat). Literature Review 0014 SC4 Provides an intuitive touchscreen user interface with guided workflows and clear process / status indicators Literature Review 0014 SC5 Compact, mobile system suitable for OR environments, with ergonomic features that support perfusionist / auto-transfusionist workflow. Literature Review 0014 SC6 Includes alarms and safety interlocks for process parameters, vacuum, fluid levels, and product quality, with reliability appropriate for high use OR settings. Literature Review 0014 SC7 Cleared/approved as an autotransfusion device under applicable regulations and standards Literature Review 0014 SC # Salient Characteristics Method of Evaluation Applicable CLINs Page # Where SC is Found in Technical Literature SC8 Uses single use disposable sets that are quick to install and prime, minimizing setup time and steps. Literature Review 0001 - 0013 SC # Salient Characteristics Method of Evaluation Applicable CLINs Page # Where SC is Found in Technical Literature SC9 Supports intraoperative and postoperative autologous blood collection, processing, and reinfusion for medium to high blood loss procedures (cardiac, orthopedic, trauma, vascular, transplant, OBGYN).. Literature Review 0001 - 0014 The following attachments are incorporated by reference. All criteria outlined in the attachments are applicable to this combined synopsis/solicitation.
